Table 1.
Characteristic of the included randomised controlled trials.
Fig 1.
Flow chart of study selection process.
Table 2.
Risk of bias assessments of the included studies.
Fig 2.
Forest plot of fasting blood glucose level at end of treatment, Fuling formulae plus hypoglycaemic agents versus hypoglycaemic agents alone, results of meta-analysis.
Table 3.
Summary of meta-analysis results and sub-group analysis.
Fig 3.
Forest plot of 2-hour postprandial blood glucose level at end of treatment, Fuling formulae plus hypoglycaemic agents versus hypoglycaemic agents alone, results of meta-analysis.
Fig 4.
Forest plot of hemoglobin A1c level at end of treatment, Fuling formulae plus hypoglycaemic agents versus hypoglycaemic agents alone, results of meta-analysis.
Table 4.
GRADE: Quality of the evidence of Fuling formulae for T2DM, CHM plus Hypoglycaemic agents vs. Hypoglycaemic agents.